These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17521906)

  • 21. [The importance of the I-colic time in colorectal cancer with synchronous hepatic metastases. Specifics of surgical strategy].
    Moldovan B; Copotoiu C; Bud V; Nemes I; Serac G; Molnar C; Florea S; Cornăteanu S; Milutin D; Coţovanu A; Pocreaţă D
    Chirurgia (Bucur); 2008; 103(5):539-46. PubMed ID: 19260629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
    Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
    Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
    Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Talaporfin sodium.
    Wang S; Bromley E; Xu L; Chen JC; Keltner L
    Expert Opin Pharmacother; 2010 Jan; 11(1):133-40. PubMed ID: 20001435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New concepts in the therapeutic options of liver metastases from colorectal cancer.
    Andromanakos N; Filippou D; Papadopoulos V; Kouraklis G; Christianakis E; Kostakis A
    J BUON; 2007; 12(4):445-52. PubMed ID: 18067201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
    Dizon DS; Schwartz J; Kemeny N
    Surg Oncol Clin N Am; 2008 Oct; 17(4):759-71, viii. PubMed ID: 18722916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated options for liver-limited metastatic colorectal cancer.
    Alberts SR
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
    Marshall JL
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic arterial infusion: the beginning of the combination era.
    Pestalozzi BC; Gruttadauria S; Clavien PA
    J Clin Oncol; 2008 May; 26(13):2231-2; author reply 2232-3. PubMed ID: 18445857
    [No Abstract]   [Full Text] [Related]  

  • 35. Unresectable liver metastases from colorectal cancer and hepatic arterial infusion chemotherapy: how, when and to whom?
    Viúdez A; Rodríguez J; Gil-Bazo I
    Cardiovasc Intervent Radiol; 2009 May; 32(3):603-4. PubMed ID: 19194743
    [No Abstract]   [Full Text] [Related]  

  • 36. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
    Kandutsch S; Klinger M; Hacker S; Wrba F; Gruenberger B; Gruenberger T
    Eur J Surg Oncol; 2008 Nov; 34(11):1231-6. PubMed ID: 18272318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The second report from Sapporo Tsukisamu hospital--chemotherapy for patients with advanced colorectal cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1241-7. PubMed ID: 17687205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy for metastatic colorectal cancer to the liver: from chemotherapy to targeting therapy.
    Teng LS; Zheng Y; Zhang J
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):569-70. PubMed ID: 19073400
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancers of the large bowel and hepatobiliary tract.
    Stevenson JP; O'Dwyer PJ
    Cancer Chemother Biol Response Modif; 2001; 19():547-71. PubMed ID: 11686032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.